Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with adverse cardiac outcomes. This review discusses currently available noninvasive imaging techniques, provides insights into their strengths and limitations, and examines novel developments that will affect the future of noninvasive imaging of myocardial fibrosis.
EditorsEditor-in-ChiefY.S. Chandrashekhar, MD, DM, FACCCME EditorRagavendra R. Baliga, MDAuthorsYin Ge, MDAmitoj Singh, MDRaymond Y. Kwong, MD, MPHImportant DatesDate of Release: December 6, 2021Term of Approval/Date of CME/MOC/ECME Expiration: December 5, 2022